Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huse

Showing results (791-800 of 967) with videos related to

Pageof 97
Sort By:
Frontiers in Immunology|July 3, 2024
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative studySarah Louise Murphy, Nora Reka Balzer, Trine Ranheim, et al.
The Journal of Clinical Investigation|April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of gliomaYujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Cancer Cell|September 10, 2024
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrenceSpencer S Watson, Anoek Zomer, Nadine Fournier, et al.
Structural Dynamics (Melville, N.Y.)|February 10, 2021
Shot noise limited soft x-ray absorption spectroscopy in solution at a SASE-FEL using a transmission grating beam splitterRobin Y Engel, Maria Ekimova, Piter S Miedema, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Mechanoimmunological Control of Metastatic Site SelectionYassmin A Elbanna, Maria Tello-Lafoz, Aliya Holland, et al.
Nature Genetics|January 4, 2007
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1Jochen Hampe, Andre Franke, Philip Rosenstiel, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Nature|February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeSevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Ebiomedicine|September 19, 2016
Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are PredictiveStefan Taudien, Ludwig Lausser, Evangelos J Giamarellos-Bourboulis, et al.
Pageof 97

Showing results (791-800 of 967) with videos related to

Sort By:
Pageof 97
Frontiers in Immunology|July 3, 2024
Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative studySarah Louise Murphy, Nora Reka Balzer, Trine Ranheim, et al.
The Journal of Clinical Investigation|April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of gliomaYujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.
Cancer Cell|September 10, 2024
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrenceSpencer S Watson, Anoek Zomer, Nadine Fournier, et al.
Structural Dynamics (Melville, N.Y.)|February 10, 2021
Shot noise limited soft x-ray absorption spectroscopy in solution at a SASE-FEL using a transmission grating beam splitterRobin Y Engel, Maria Ekimova, Piter S Miedema, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Mechanoimmunological Control of Metastatic Site SelectionYassmin A Elbanna, Maria Tello-Lafoz, Aliya Holland, et al.
Nature Genetics|January 4, 2007
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1Jochen Hampe, Andre Franke, Philip Rosenstiel, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Nature|February 21, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeSevin Turcan, Daniel Rohle, Anuj Goenka, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Ebiomedicine|September 19, 2016
Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are PredictiveStefan Taudien, Ludwig Lausser, Evangelos J Giamarellos-Bourboulis, et al.
Pageof 97